Literature DB >> 31720720

[Turning point in skin cancer mortality : An analysis of the trend in Germany from 1998 to 2017].

Joachim Hübner1, Franziska Hübner2, Patrick Terheyden2, Alexander Katalinic3,4.   

Abstract

Including non-melanocytic types, skin cancer is still the most common cancer in Germany. The objective of this study is to investigate current trends of skin cancer mortality in Germany. Data of the death statistics from 1998 to 2017 were analyzed using joinpoint regression models. Age standardized skin cancer mortality declined since 2013 (annual percentage change -2.1% [95% CI: -4.0 to -0.2%]), while in previous years an increase of +3.4% (95% CI: 1.3 to 5.4%) was observed. The development is mainly driven by a decreasing melanoma mortality. Possible causes of the trend change are especially the nationwide skin cancer screening which was introduced in 2008 and the growing availability of new systemic therapies from about 2011. Further research is needed to estimate the extent of the respective causal contributions.

Entities:  

Keywords:  Epidemiology; Melanoma; Non-melanocytic skin cancer; Skin cancer screening; Treatment options

Mesh:

Year:  2019        PMID: 31720720     DOI: 10.1007/s00105-019-04504-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Systematic skin cancer screening in Northern Germany.

Authors:  Eckhard W Breitbart; Annika Waldmann; Sandra Nolte; Marcus Capellaro; Ruediger Greinert; Beate Volkmer; Alexander Katalinic
Journal:  J Am Acad Dermatol       Date:  2011-11-08       Impact factor: 11.527

2.  Declining incidence of keratinocyte carcinoma in organ transplant recipients.

Authors:  S Menzies; E O'Leary; G Callaghan; M Galligan; S Deady; B Gadallah; P Lenane; A Lally; D D Houlihan; P G Morris; D J Sexton; P A McCormick; J J Egan; J P O'Neill; P J Conlon; F J Moloney
Journal:  Br J Dermatol       Date:  2019-11       Impact factor: 9.302

Review 3.  The Systemic Treatment of Melanoma.

Authors:  Patrick Terheyden; Angela Krackhardt; Thomas Eigentler
Journal:  Dtsch Arztebl Int       Date:  2019-07-22       Impact factor: 5.594

4.  Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.

Authors:  Alexander Katalinic; Annika Waldmann; Martin A Weinstock; Alan C Geller; Nora Eisemann; Ruediger Greinert; Beate Volkmer; Eckhard Breitbart
Journal:  Cancer       Date:  2012-04-19       Impact factor: 6.860

5.  Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors:  Jedd D Wolchok; Vanna Chiarion-Sileni; Rene Gonzalez; Piotr Rutkowski; Jean-Jacques Grob; C Lance Cowey; Christopher D Lao; John Wagstaff; Dirk Schadendorf; Pier F Ferrucci; Michael Smylie; Reinhard Dummer; Andrew Hill; David Hogg; John Haanen; Matteo S Carlino; Oliver Bechter; Michele Maio; Ivan Marquez-Rodas; Massimo Guidoboni; Grant McArthur; Celeste Lebbé; Paolo A Ascierto; Georgina V Long; Jonathan Cebon; Jeffrey Sosman; Michael A Postow; Margaret K Callahan; Dana Walker; Linda Rollin; Rafia Bhore; F Stephen Hodi; James Larkin
Journal:  N Engl J Med       Date:  2017-09-11       Impact factor: 91.245

6.  16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010.

Authors:  D M Parkin; L Boyd; L C Walker
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

7.  Melanoma mortality following skin cancer screening in Germany.

Authors:  Mathieu Boniol; Philippe Autier; Sara Gandini
Journal:  BMJ Open       Date:  2015-09-15       Impact factor: 2.692

  7 in total
  2 in total

1.  Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010-2020-Cohort Study Based on Administrative Data.

Authors:  Thomas Datzmann; Jochen Schmitt; Saskia Fuhrmann; Martin Roessler; Friedegund Meier; Olaf Schoffer
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

2.  [Statutory skin cancer screening in Germany : Motivation and motives for participation versus nonparticipation].

Authors:  G Girbig; M Augustin; M Krensel; V Andrees
Journal:  Hautarzt       Date:  2021-07-05       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.